THREE registered medicines have been granted extensions of indications by the TGA during October: Abbvie's Humira along with Onglyza and Qtern 5/10 both from AstraZeneca.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 11 Nov 16
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Nov 16
